News

Infant formula guidelines are in dire need of an FDA update, experts say. Here’s a look at some of the concerns an ...
Read Our Latest Stock Report on Abbott Laboratories Abbott Laboratories Stock Performance NYSE ABT opened at $131.00 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.14 and a ...
Tyler Pasciak LaRiviere/Sun-Times Share Abbott Laboratories is doubling down on local investment, as President Donald Trump’s shifting tariff policy continues to cause hand-wringing over the ...
Abbott Laboratories (NYSE:ABT – Get Free Report) shot up 4.9% during trading on Wednesday following a better than expected earnings announcement.The company traded as high as $133.26 and last ...
Abbott Laboratories plans to hire as many as 200 more people over the next few years to expand production in the northern suburbs of Chicago — news that comes as the company prepares to deal ...
If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories (NYSE: ABT). Abbott is a longtime leader in the ...
Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical devices. Sales were also higher at its pharmaceutical unit, but fell at its diagnostics and ...
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with an Outperform rating and a price target of $130 in a note Tuesday, citing a favorable risk/reward profile.
Abbott's medtech division has consistently contributed to overall growth, with expectations for double-digit expansion from 2024 to 2026. Abbott's stock is currently valued at 22.3 times the ...
Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...
Abbott Laboratories is now a $183 billion (by market cap) healthcare titan. Abbott Laboratories has increased its dividend for more than 50 consecutive years. So it has the kind of dividend growth ...